Proia D - Search Results

1

Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers.

Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, Kuperwasser C. Gupta PB, et al. Among authors: proia d. Cancer Res. 2007 Mar 1;67(5):2062-71. doi: 10.1158/0008-5472.CAN-06-3895. Cancer Res. 2007. PMID: 17332335

2

Stroma: tumor agonist or antagonist.

Proia DA, Kuperwasser C. Proia DA, et al. Cell Cycle. 2005 Aug;4(8):1022-5. doi: 10.4161/cc.4.8.1903. Epub 2005 Aug 7. Cell Cycle. 2005. PMID: 16082203 Review.

3

Reconstruction of human mammary tissues in a mouse model.

Proia DA, Kuperwasser C. Proia DA, et al. Nat Protoc. 2006;1(1):206-14. doi: 10.1038/nprot.2006.31. Nat Protoc. 2006. PMID: 17406234

4

Network analysis identifies an HSP90-central hub susceptible in ovarian cancer.

Liu H, Xiao F, Serebriiskii IG, O'Brien SW, Maglaty MA, Astsaturov I, Litwin S, Martin LP, Proia DA, Golemis EA, Connolly DC. Liu H, et al. Clin Cancer Res. 2013 Sep 15;19(18):5053-67. doi: 10.1158/1078-0432.CCR-13-1115. Epub 2013 Jul 30. Clin Cancer Res. 2013. PMID: 23900136 Free PMC article.

5

Ganetespib and HSP90: translating preclinical hypotheses into clinical promise.

Proia DA, Bates RC. Proia DA, et al. Cancer Res. 2014 Mar 1;74(5):1294-300. doi: 10.1158/0008-5472.CAN-13-3263. Epub 2014 Feb 20. Cancer Res. 2014. PMID: 24556722 Review.

6

A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer.

Gaponova AV, Nikonova AS, Deneka A, Kopp MC, Kudinov AE, Skobeleva N, Khazak V, Ogawa LS, Cai KQ, Duncan KE, Duncan JS, Egleston BL, Proia DA, Boumber Y, Golemis EA. Gaponova AV, et al. Clin Cancer Res. 2016 Oct 15;22(20):5120-5129. doi: 10.1158/1078-0432.CCR-15-3068. Epub 2016 Jun 7. Clin Cancer Res. 2016. PMID: 27267850 Free PMC article.

7

Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancer.

Proia DA, Zhang C, Sequeira M, Jimenez JP, He S, Spector N, Shapiro GI, Tolaney S, Nagai M, Acquaviva J, Smith DL, Sang J, Bates RC, El-Hariry I. Proia DA, et al. Clin Cancer Res. 2014 Jan 15;20(2):413-24. doi: 10.1158/1078-0432.CCR-13-2166. Epub 2013 Oct 30. Clin Cancer Res. 2014. PMID: 24173541

8

FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism.

Acquaviva J, He S, Zhang C, Jimenez JP, Nagai M, Sang J, Sequeira M, Smith DL, Ogawa LS, Inoue T, Tatsuta N, Knowles MA, Bates RC, Proia DA. Acquaviva J, et al. Mol Cancer Res. 2014 Jul;12(7):1042-54. doi: 10.1158/1541-7786.MCR-14-0004. Epub 2014 Apr 30. Mol Cancer Res. 2014. PMID: 24784839 Free article.

9

HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors.

Proia DA, Smith DL, Zhang J, Jimenez JP, Sang J, Ogawa LS, Sequeira M, Acquaviva J, He S, Zhang C, Khazak V, Astsaturov I, Inoue T, Tatsuta N, Osman S, Bates RC, Chimmanamada D, Ying W. Proia DA, et al. Mol Cancer Ther. 2015 Nov;14(11):2422-32. doi: 10.1158/1535-7163.MCT-15-0455. Epub 2015 Aug 13. Mol Cancer Ther. 2015. PMID: 26271675

10

Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with Chemoradiation.

Wang Y, Liu H, Diao L, Potter A, Zhang J, Qiao Y, Wang J, Proia DA, Tailor R, Komaki R, Lin SH. Wang Y, et al. Among authors: proia da. Clin Cancer Res. 2016 Dec 1;22(23):5876-5886. doi: 10.1158/1078-0432.CCR-15-2190. Epub 2016 Jun 28. Clin Cancer Res. 2016. PMID: 27354472 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters